Furthermore, the combined measurement of CK18‐M65 and CK18‐M30 demonstrated strong discriminatory ability for identifying NAFLD patients with concurrent CHD in this study, highlighting their potential diagnostic utility as complementary biomarkers. Here, KRT18 is linked to coronary artery disorder.